The Push for Side-by-Side Prescription Pricing in EHR Workflows

Why It Matters

Providing comparative, actionable price data at the point of prescribing reduces abandonment, boosts medication adherence, and lowers overall healthcare spending.

Key Takeaways

• 75% of prescribers cite out‑of‑pocket cost as major barrier
• 94% value seeing insurance and cash prices side‑by‑side
• Only 17% have highly visible prescription fulfillment data
• 54% report patients often abandon therapy due to cost
• 63% seek discount or cash options when coverage fails

Pulse Analysis

Rising drug prices have turned prescribing into a financial negotiation as much as a clinical decision. Patients across commercial, Medicare and Medicaid plans face steep out‑of‑pocket expenses, prompting clinicians to discuss cost during every visit. When cost information is buried or delayed, prescribers either switch therapies, cancel orders, or leave patients without a clear path to access, driving higher abandonment rates and inflating total health‑system costs.

Buzz Health’s recent survey of prescribers and technology leaders quantifies this friction. While 77% already see some price data in their EHR, only 17% report high visibility into fulfillment outcomes, and 54% admit patients frequently forgo therapy due to cost concerns. The data reveal a clear preference for side‑by‑side pricing: 94% say viewing insurance‑based and cash‑discount options together would be extremely valuable, and 79% rate such comparative displays as useful. By surfacing multiple price points instantly, clinicians can steer patients toward the most affordable, covered option, reducing decision‑making time and improving the likelihood of a filled prescription.

Implementing true comparative pricing requires integrated, real‑time benefit adjudication and API‑driven discount networks within the EHR workflow. Configurable comparison tools that present copays alongside eligible cash prices, coupled with automated routing to discount pathways, eliminate manual handoffs and preserve data for analytics. As health systems adopt these capabilities, they gain closed‑loop visibility into both covered and cash transactions, enabling better measurement of affordability initiatives and supporting value‑based care goals. The next wave of e‑prescribing innovation will focus on turning price transparency into price certainty, aligning clinical intent with financial reality for patients and providers alike.